Shell Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Shell Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-68,344	Closed	-$212K	–	1406
2021 Q4	$212K	Buy	68,344 +322	+0.5%	+$1.08K	﹤0.01%	1196
2021 Q3	$246K	Sell	68,022 -2,930	-4%	-$11.1K	0.01%	1141
2021 Q2	$254K	Buy	70,952 +46,881	+195%	+$165K	﹤0.01%	1172
2021 Q1	$94K	Buy	+24,071	New	+$99.4K	﹤0.01%	1301

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Shell Asset Management's BDSI Position: Q1 2022 in Review

Shell Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 68,344 shares — an estimated $212K sold.

Shell Asset Management first reported a position in BDSI in Q1 2021 and held it in 4 quarters. The position peaked at $254K in Q2 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Shell Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Shell Asset Management sold 68,344 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $212K.
Shell Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2021 and held it in 4 quarters.
Shell Asset Management's BioDelivery Sciences International, Inc. position peaked at $254K in Q2 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Shell Asset Management's 13F filing for Q1 2022, filed 4 May 2022.